449 related articles for article (PubMed ID: 29747655)
21. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
22. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
Patel A; Malik M; Britten J; Cox J; Catherino WH
Fertil Steril; 2016 Apr; 105(4):1102-10. PubMed ID: 26776909
[TBL] [Abstract][Full Text] [Related]
23. Psychosocial Stress and MicroRNA Expression Profiles in Myometrial Tissue of Women Undergoing Surgical Treatment for Uterine Fibroids.
Dye CK; Wu H; VanNoy B; Calluori S; Marfori CQ; Baccarelli AA; Zota AR
Reprod Sci; 2024 Jun; 31(6):1651-1661. PubMed ID: 38379067
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells.
Islam MS; Castellucci C; Fiorini R; Greco S; Gagliardi R; Zannotti A; Giannubilo SR; Ciavattini A; Frega NG; Pacetti D; Ciarmela P
J Cell Physiol; 2018 Sep; 233(9):7143-7156. PubMed ID: 29574773
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family.
Chuang TD; Quintanilla D; Boos D; Khorram O
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34491311
[TBL] [Abstract][Full Text] [Related]
26. miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1.
Zhao W; Zhao Y; Chen L; Sun Y; Fan S
Comput Math Methods Med; 2022; 2022():2329576. PubMed ID: 35082911
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium.
Malik M; Catherino WH
Fertil Steril; 2012 Jun; 97(6):1287-93. PubMed ID: 22425196
[TBL] [Abstract][Full Text] [Related]
28. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
[TBL] [Abstract][Full Text] [Related]
29. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.
New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA
Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids.
Zaitseva M; Holdsworth-Carson SJ; Waldrip L; Nevzorova J; Martelotto L; Vollenhoven BJ; Rogers PA
Reproduction; 2013 Aug; 146(2):91-102. PubMed ID: 23704310
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract][Full Text] [Related]
32. Effects of Phthalate Esters on Human Myometrial and Fibroid Cells: Cell Culture and NOD-SCID Mouse Data.
Kim HJ; Kim SH; Oh YS; Heo SH; Kim KH; Kim DY; Lee SR; Chae HD
Reprod Sci; 2021 Feb; 28(2):479-487. PubMed ID: 33037561
[TBL] [Abstract][Full Text] [Related]
33. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
34. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p.
Yang E; Xue L; Li Z; Yi T
BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799
[TBL] [Abstract][Full Text] [Related]
35. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
38. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.
Chuang TD; Ton N; Manrique N; Rysling S; Khorram O
Clin Sci (Lond); 2024 Jun; 138(12):699-709. PubMed ID: 38817011
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome Analyses of Myometrium from Fibroid Patients Reveals Phenotypic Differences Compared to Non-Diseased Myometrium.
Paul EN; Burns GW; Carpenter TJ; Grey JA; Fazleabas AT; Teixeira JM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807176
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.
Zaitseva M; Vollenhoven BJ; Rogers PA
Mol Hum Reprod; 2007 Aug; 13(8):577-85. PubMed ID: 17553814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
